The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

[1] The purpose of this review paper is to analyze the role of the kidney in glucose homeostasis, emphasizing in SGLT2 inhibition ... Urinary glucose excretion (g/24 h):/DP100 mg: 69.9/DP20 ...

Because SGLT2 inhibitors act on the kidney, and the amount of glucose ... which showed a reduction in urinary glucose excretion of ~85% in T2DM patients with moderate to severe renal impairment ...

A new study finds SGLT2 inhibitors like Jardiance and GLP-1 drugs like Ozempic provide different benefits depending on the ...

Clinical data, including gender, age at the time of renal biopsy, and systolic/diastolic blood pressure, serum creatine, hematuria and 24-h urine protein excretion ... we found that treatment with ...

SGLT2, with high volume and low affinity ... while SDMA is mainly cleared through renal excretion (120). S-adenosine homocysteine is a by-product of methionine methyl transfer reaction and a precursor ...

Starting SGLT2 inhibitors led to a lower risk of eGFR decline or incident kidney failure. SGLT2 inhibitors were also linked to reduced amputation and AKI risks. Use of SGLT2 inhibitors was ...

“Our data suggest SGLT2 inhibition as a safe strategy to prevent kidney stone recurrence in patients with kidney stones ,” Dr Fuster’s team concluded. Other study findings indicate the empagliflozin ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...